Non-alcoholic fatty liver disease (NAFLD) affects 25% of the world's population — it is the most common chronic liver disease. Its progression to NASH (steatohepatitis) and then cirrhosis makes it a major concern. Ginger offers remarkable liver protection.
Ginger and liver fat reduction
A randomized clinical trial (Phytotherapy Research, 2022) on 46 NAFLD patients shows that 2 g of ginger/day for 12 weeks:
- Reduces liver steatosis by 25% (measured by ultrasound)
- Decreases ALT by 28% and AST by 22%
- Reduces GGT by 18%
- Improves FIB-4 fibrosis score
Hepatoprotective mechanisms
- Lipogenesis: gingerol inhibits SREBP-1c, reducing the synthesis of new fats in the liver
- β-oxidation: stimulates the burning of liver fats via PPARα and CPT-1
- anti-inflammatory ginger: reduces inflammation (NAFLD → NASH transition) via NF-κB and NLRP3
- Anti-fibrotic: inhibits activation of hepatic stellate cells, preventing fibrosis
- Antioxidant: protects hepatocytes against lipid peroxidation
Fructose and NAFLD: the crucial link
Fructose is the main nutrient responsible for NAFLD — it is metabolized exclusively by the liver and converted directly into liver fat. A ginger shot containing cane sugar (rich in fructose) is counterproductive for a fatty liver. INTI, with 1.19 g of sugar/100 ml and zero added sugar, protects the liver without harming it.
INTI Protocol for NAFLD/NASH
- Early NAFLD: 2 INTI shots/day (morning + evening)
- NASH/elevated enzymes: 3 INTI shots/day before meals
- Control: liver panel (ALT, AST, GGT) at 8 and 12 weeks
Conclusion
Ginger reduces liver steatosis, normalizes enzymes, and slows progression to NASH. INTI Drink — ginger + turmeric, zero added fructose — is the ideal hepatoprotective supplement.